Dam Apotheek SRL
Dam Apotheek reported total assets of 376,083 € at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Aug 2026).
The score of Dam Apotheek shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +81 % Total assets +253 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dam Apotheek's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −11,144 € | ||||
| Equity | 145,939 € | ||||
| Cash | 53,514 € | ||||
| EBITDA | −7,185 € | ||||
| Total assets | 376,083 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 13 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 23 Aug 2022
Dam Apotheek's financial analysis
- Solvency38.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dam Apotheek
Dam Apotheek's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0404.805.843
- VAT number
- BE0404805843
- Peppol
- Registered · 0208:0404805843 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Jan 1968
- Registered office
- 2060 Antwerp
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dam Apotheek (SRL) has been based in Antwerp since 1968, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 11,144 € and equity of 145,939 €; its revenue is not published. Its solvency stands at 38.8%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dam Apotheek
Companies in the same business, of comparable size and area, outside its group.
- Vaveo Retail sale of pharmaceutical products Antwerp · balance sheet 446,113 €
- Bio - Vitalpharma Retail sale of pharmaceutical products Antwerp · balance sheet 532,020 €
- Pharmacie Willemsen Retail sale of pharmaceutical products Anderlecht · balance sheet 307,927 €
- Milpharma Retail sale of pharmaceutical products Riemst · balance sheet 502,955 €
- Biologie Clinique Anne Tamigniau Retail sale of pharmaceutical products Namur · balance sheet 381,762 €
- Grote Markt Retail sale of pharmaceutical products Blankenberge · balance sheet 398,982 €
- License to care Retail sale of pharmaceutical products Duffel · balance sheet 702,743 €
- Proxypharma LLB Retail sale of pharmaceutical products La Bruyère · balance sheet 707,554 €
Frequently asked questions about Dam Apotheek
What is the revenue of Dam Apotheek?
Dam Apotheek files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dam Apotheek?
In Belgium, the VAT number is the company number prefixed with BE: BE0404805843 for Dam Apotheek, if the company is VAT-registered. Its company number (CBE) is 0404.805.843.
Where is the registered office of Dam Apotheek?
According to the CBE register, the registered office of Dam Apotheek is in 2060 Antwerp.
What is the equity of Dam Apotheek?
At the close of the 2025 financial year, the equity of Dam Apotheek amounts to 145,939 €, a solvency of 38.8% of total assets.
Who manages Dam Apotheek?
The register lists 6 active mandates at Dam Apotheek. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dam Apotheek
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →